Show simple item record

dc.contributor.authorKELLEHER, DERMOT P
dc.contributor.authorO'FARRELLY, CLIONA
dc.date.accessioned2009-10-23T16:22:35Z
dc.date.available2009-10-23T16:22:35Z
dc.date.issued1996
dc.date.submitted1996en
dc.identifier.citationAbuzakouk, M, Kelleher, D, Feighery, C, O'Farrelly, C. `Increased HLA-DR and decreased CD3 on human intestinal intraepithelial lymphocytes: evidence of activation?? Gut, 39, (3), 1996, pp 396-400en
dc.identifier.otherYen
dc.identifier.otherY
dc.identifier.other54087
dc.descriptionPUBLISHEDen
dc.description.abstractBACKGROUND: Activation of circulating T lymphocytes results in expression of HLA-DR, interleukin-2 receptor (IL-2R), transferrin receptor (TrR), and decreased amounts of surface CD3. AIM: To examine the activation status of human intestinal intraepithelial lymphocytes (IELs) by flow cytometry. PATIENTS AND METHODS: Duodenal biopsy specimens from 12 patients provided a source of intestinal lymphocytes. Dual colour analysis was used to compare activation marker expression by IELs with peripheral blood (PB) T lymphocytes from the same patients. RESULTS: All human IEL populations express HLA-DR and their density of expression is lower than on the small population of HLA-DR+ resting PB T lymphocytes (mean fluorescence intensity (MFI) 52.9, range 19.8-94.8 v 152.6 range, 49.1-320.3; p < 0.01). The density of CD3 was significantly reduced on IELs (MFI 465.8, range 228.7-660), compared with PB T lymphocytes (756.3, range 444.5-1573.7; p < 0.009). IL-2R was not detected on IELs; nor were the activation markers, TrR, M21 C5, or M2 B3. CONCLUSION: HLA-DR expression on IELs together with decreased CD3 expression suggest previous stimulation. However, the absence of additional markers of T cell activation may reflect a unique pathway of activation.en
dc.description.sponsorshipDuring this study, MA was supported by a grant from the Ministry of Scientific Research, Libya. CO'F was supported by the Arthritis Foundation of Ireland and the Health Research Board of Ireland. DK is a Wellcome Senior Fellow in Clinical Science.en
dc.format.extent957649 bytes
dc.format.extent396-400en
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherBMJen
dc.relation.ispartofseriesGuten
dc.relation.ispartofseries39en
dc.relation.ispartofseries3en
dc.rightsYen
dc.subjectBiochemistryen
dc.titleIncreased HLA-DR and decreased CD3 on human intestinal intraepithelial lymphocytes: evidence of activation?en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/ofarrecl
dc.identifier.rssinternalid20903
dc.contributor.sponsorHealth Research Board
dc.identifier.urihttp://hdl.handle.net/2262/34192


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record